Retevmo Selpercatinib — Highmark
4 indications indexed for this drug.
- Advanced Or Metastatic Medullary Thyroid Cancer Mtc With RetView coverage criteria
- Advanced Or Metastatic Ret Fusion Positive Thyroid Cancer ReView coverage criteria
- Locally Advanced Or Metastatic Ret Fusion Positive Non SmallView coverage criteria
- Locally Advanced Or Metastatic Ret Fusion Positive Solid TumView coverage criteria